Kepos Capital’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Kepos Capital’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-150,000	Closed	-$5K	–	376
2023 Q2	$5K	Buy	+150,000	New	+$6.55K	﹤0.01%	335
2022 Q4	$4K	Hold	150,000	–	–	﹤0.01%	407
2022 Q3	$33K	Hold	150,000	–	–	﹤0.01%	328
2022 Q2	$17K	Hold	150,000	–	–	﹤0.01%	444
2022 Q1	$63K	Hold	150,000	–	–	﹤0.01%	478
2021 Q4	$60K	Buy	+150,000	New	+$103K	0.01%	591

Other funds holding APGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Kepos Capital's APGNW Position: Q3 2023 in Review

Kepos Capital sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q3 2023, closing a stake of 150,000 shares — an estimated $5K sold.

Kepos Capital first reported a position in APGNW in Q4 2021 and held it in 6 quarters. The position peaked at $63K in Q1 2022. 1 fund tracked by Wall St. Rank holds APGNW as of Q3 2023.

Kepos Capital reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
Kepos Capital sold 150,000 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q3 2023, an estimated $5K.
Kepos Capital first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q4 2021 and held it in 6 quarters.
Kepos Capital's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $63K in Q1 2022.
1 fund tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2023.

Based on Kepos Capital's 13F filing for Q3 2023, filed 14 Nov 2023.